Capital Investment Advisory Services, LLC In8 Bio, Inc. Transaction History
Capital Investment Advisory Services, LLC
- $1.04 Billion
- Q1 2025
A detailed history of Capital Investment Advisory Services, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 17,605 shares of INAB stock, worth $2,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,605Holding current value
$2,992% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
28Shares Held
25.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$1.46 Million2.31% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$968,3540.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL5.06MShares$860,7590.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$306,5020.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.45MShares$246,5000.13% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $4.17M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...